 |
| 麻州州長Charlie Baker)說明麻州分發疫苗概況。 |
接著會分配給14個郡74家醫院的第一線醫療工作人員，以及各類前線醫療工作人員。65歲以下的一般民眾，估計得等到明年春天的四月以後才能輪到他們注射疫苗。
第二批的4萬劑輝瑞疫苗將分配給聯邦藥物計畫(Federal Pharmacy Program)， 用於為護理機構，療養院及輔助居住場所。
 |
| 兩名疫苗顧問委員會委員出席記者會。 |
查詢疫苗相關資訊可上麻州政府的疫苗網站， www.mass.gov/COVIDvaccine。
經過新冠病毒疫苗顧問委員會的研議，疫苗分發將分三個階段。
今年12月到明年2月為第一期，優先順序為直接和治療，護理新冠病毒的醫護工作人員；長期護理機構、療養院及輔助居住樓宇內工作人員；警察，消防員，緊急醫護服務人員；庇護所，糾正機構等聚集場所(87000劑)；居家護理員工(115000劑)；執行非新冠病毒醫護的工作人員(130000劑)。
第二期為明年2月到4月，優先順序為患有2種合併病症，新冠病毒併發症高危個人(650,000劑)；早期教育，幼稚園到12年級，交通，雜貨，水電，食物及農業，消毒等的公立機構員工和公共衛生員工(840,000劑)；65歲成人(110萬劑)，患有一種併發症的個人(270萬劑)。
第三期為明年四月以後。估計一般大眾都可到疫苗。
Baker-Polito Administration Announces Initial Steps for COVID-19 Vaccine Distribution
BOSTON – Today, the Baker-Polito Administration announced allocation and distribution plans for the first round of COVID-19 vaccine shipments to Massachusetts set to begin around December 15. The state’s first shipment of 59,475 doses of the Pfizer vaccine was ordered from the federal government this past Friday and will be delivered directly to 21 hospitals across 8 counties, as well as to the Department of Public Health Immunization lab.
Doses will then be redistributed for access to 74 hospitals across all 14 counties for front line medical workers. The next 40,000 doses of Pfizer vaccine will be allocated to the Federal Pharmacy Program to begin vaccinating staff and residents of skilled nursing facilities, rest homes and assisted living residences.
Vaccine is being prioritized for these groups to maximize life preservation and to support the health care system. Based on information at this time, Massachusetts is expecting 300,000 first doses of the vaccine to be delivered by the end of December. The first vaccines, manufactured by Moderna and Pfizer, will require two doses administered 3-4 weeks apart.
Click here to view the administration’s vaccine website: www.mass.gov/COVIDvaccine.
Click here to view the administration’s vaccine presentation
Click here for Frequently Asked Questions
While all delivery dates and quantities are subject to change due to ongoing federal approval and allocation, the Administration plans to receive and distribute over 2 million doses to priority population groups by the end of March.
In collaboration with the COVID-19 Vaccine Advisory Group, the Administration designated groups of medical workers, first responders and residents most at risk for serious illness to receive the vaccine before the general population. The Vaccine Advisory Group is made up of leading medical, infectious disease and public health experts as well as representatives from communities of color and representatives of high-risk populations.
Communities of color and at-risk populations are prioritized throughout the process to maximize life preservation and to prevent serious complications from COVID related illnesses.
Anticipated Vaccination Phases and Timeline:
Phase One (December 2020-February 2021):
In order of priority
- Clinical and non-clinical healthcare workers doing direct and COVID-facing care
- Long term care facilities, rest homes and assisted living facilities
- Police, Fire and Emergency Medical Services
- Congregate care settings (including shelters and corrections)
- Home-based healthcare workers
- Healthcare workers doing non-COVID facing care
Phase Two (February 2021-April 2021):
In order of priority
- Individuals with 2+ comorbidities (high risk for COVID-19 complications)
- Early education, K-12, transit, grocery, utility, food and agriculture, sanitation, public works and public health workers
- Adults 65+
- Individuals with one comorbidity
Phase Three (April 2021- ):
- Vaccine available to general public
The first shipments of the vaccine are expected to contain doses manufactured by Pfizer and Moderna. While both Pfizer and Moderna vaccines are pending FDA emergency use authorization, Massachusetts will not distribute the COVID-19 vaccine until it receives this authorization.
Vaccines go through extensive testing, more than any pharmaceuticals, including extensive testing in clinical trials. The FDA, which approves the vaccine, and the CDC’s Advisory Committee on Immunization Practices (ACIP), which will make its recommendation for use, must ensure any vaccine is both safe and effective for the public before approval and distribution.
The infectious disease experts in the state’s academic medical centers have pledged to review the EUA data and provide an independent opinion about their safety and efficacy.
All residents should visit www.mass.gov/COVIDVaccine to learn more or contact their medical provider for questions about their vaccination plans.
沒有留言:
發佈留言